Vic and Marcus discuss the return of Trump's tariffs, the Federal Reserve's evolving approach under Chairman Warsh, and the continued strength of AI infrastructure as Microsoft and Amazon report surging cloud growth. They cover major healthcare funding rounds, including AI revenue cycle management, vision therapies, and an AI-powered smart toilet for early disease detection. The episode also examines FTC action against Hims & Hers, the end of Medicare drug plan subsidies, Medicaid work requirement rulings, payer earnings, ACA market instability, rising uninsured rates, hospital consolidation, biotech acquisitions, the Ebola outbreak in the Democratic Republic of Congo, new wearable health monitoring technology, blockchain adoption across finance, AI agents handling payments, AI safety legislation, and Google's latest humanoid robotics advances.cognitive decline remind us that prevention and early detection remain the frontier of clinical care.
Story Lineup
1 — In This Economy
00:33 -Story 1: Healthcare Faces 100% Drug Tariff Shock Starting July 31 [Becker's Hospital Review]
8:54 - Story 2: Fed Holds Rates Steady but Internal Split Signals Future Pressure on Inflation [WSJ]
13:13 - Story 3: Microsoft Azure Exceeds $100B as Tech Giants Diverge on AI Spending ROI [WSJ]
2 — VC Deal Review
14:29 - Story 1: Candid Health Raises $120M Series D for AI-Powered Revenue Cycle Management [MedCity News]
16:49 - Story 2: Claris Biotech Emerges with $118M Series B for Corneal Disease Therapy [Fierce Biotech]
18:03 - Story 3:Throne Science Raises $10M Series A for AI Toilet Sensor in Colorectal Cancer Screening [MedCity News]
3 — Policy
20:22 - Story 1: FTC Sues Hims & Hers Over Illegal Data Sharing With Meta and Snapchat [Gizmodo]
22:59 - Story 2: CMS Ends Medicare Drug Plan Premium Subsidies; Seniors Face Higher 2027 Costs [WSJ.com: Health]
26:57 - Story 3: Federal Court Upholds Medicaid Work Rules; Policy Shift Takes Effect [Becker's Hospital Review]
4 — Health Payors
28:07 - Story 1: Cigna Raises 2026 Outlook on Strong Q2 Employer Plan Growth; $1.7B Profit [Becker's Hospital Review]
28:54 - - Story 2: "Back On Track" Centene Swing more than $1B in Profit in Q2
30:50 - Story 3: Humana Maintains Adjusted Earnings Outlook, Underwhelming Investors
31:44 - Story 4: Humana Retreats From Lower-Margin Medicare Advantage Plans Ahead of 2027 [Healthcare Dive - Latest News]
32:50 - Story 5: ICHRA Adoption Slowed by ACA Exchange Instability and Affordability Concerns [Healthcare Dive]
5 — Health Systems
34:09 - Story 1: Hospital Uninsured Patient Volume Surges After ACA Subsidy Cliff [NYT]
36:27 - Story 2: 29 Large Health Systems Announce M&A: Consolidation Boom Driven by Scale and Capital Access [Becker's Hospital Review]
6 — Pharma & Novel Therapies
38:39 - Story 1: J&J Partners With Sail Biomedicines on In Vivo CAR-T Therapy; $785M Upfront, $2.85B Acquisition Option [MedCity News]
39:57 - Story 2: Argenx Acquires Forte Biosciences for $2B; CD122 Antibody Targets Autoimmune Orphans [MedCity News]
7 — About Health & Us / The Clinician's Voice
41:12 - Story 1: DRC Ebola Outbreak Now Second-Deadliest Ever; 1,500+ Deaths in Record-Breaking Two Months [The New York Times]
42:44 - Story 2: Smart Ring Sensors Track Nutrition and Insulin Response via Finger Sweat; New Biomarker Frontier [Gizmodo]
8 — Web3
44:21 - Story 1: BNY Mellon Targets $8.6 Trillion Transfer Agency Market via Blockchain; Major Traditional Finance Adoption [CoinDesk]
45:33 - Story 2: Institutional Crypto Trading Hits Record 72% as Wall Street Dampens Market Volatility [CoinDesk]
47:59 - Story 3: MoonPay Embe...
